Tricor notice plan is approved in antitrust case
Teva Pharmaceuticals USA, Inc. et al., v. Abbott Laboratories et al. No. 02-1512-SLR; Impax Laboratories, Inc. v. Abbott Laboratories, et al., No. 03-120-SLR; In re Tricor Direct Purchaser Antitrust Litigation No. 05-340-SLR; In Re: Tricor Indirect Purchaser Antitrust Litigation No. 05-360-SLR, October 8, 2008.
Robinson, J. The Indirect Purchasers Plaintiffs’ motion for approval of their proposed notice plan is granted.
This case involves antitrust claims asserted against the defendant companies involved in the sale of the pharmaceutical product Tricor©. A notice administrator is appointed and a Tricor© Litigation webpage is to be created providing access to the class of indirect purchasers of Tricor© along with other notice requirements.
